Strepsils maker Reckitt buoyed by winter bugs

A surge in winter cold and flu bugs helped Nurofen and Strepsils maker Reckitt Benckiser report better-than-expected profits today.

Strepsils maker Reckitt buoyed by winter bugs

A surge in winter cold and flu bugs helped Nurofen and Strepsils maker Reckitt Benckiser report better-than-expected profits today.

The company, whose brands also include Durex and Dettol, finished last year with quarterly like-for-like sales growth of 6%, with its Europe and North America region up 3% due to strong demand for seasonal brands.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited